Delivery Order SPE2DR25D3020-SPE2DR26F9P6M
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $26,313.07 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract does not include a set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $7,732.88 and completion date of December 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a key distribution center...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 200 mg/1.14 ml syringes with a ceiling value of $3,486.88. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $12,767.10, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $38,433.94 on December 5, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of December 8, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary operations center. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dupixent 300 mg/2 mL syringes with a contract value of $6,837.84. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $4,574.98. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for ultimate completion by December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and operates as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 23, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $3,603.02. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by November 24, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $57,226.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, with performance of work taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $4,708.90 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 5, 2025, with completion anticipated by December 8, 2025. This firm fixed-price contract, which is not set-aside, leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- SPE2DR25D3020Indefinite Delivery Contract
- SPE2DR25D3020-SPE2DR26F9P6MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $17,351.77. The contract is a firm fixed price delivery order with an ultimate completion date of December 5, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's performance location for this order is Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor supporting federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order demonstrates AmerisourceBergen's continued role as a critical vendor for federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 12/3/25 |